Company Filing History:

24 out of 4,942

Hoffmann-la Roche Inc.

Years Active: 1985-2009

Loading Chart...

26 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 7619101 - Process for the preparation of (S)-4-fluoromethyl-dihydro-furan-2-one useful in the preparation of the DPP-IV inhibitor (S)-1 ((2S,3S,11bS)-2-amino-9,10-dimethoxy-1,3,4,6,7, 11b-hexahydro-2H-pyrido[2,1-a] isoquinolin-3-yl)-4-fluoromethyl-pyrrolidin-2-one (2009-11-17),

2. 7312343 - Synthesis of α-amino-β-alkoxy-carboxylic acid esters (2007-12-25),

3. 7169943 - Manufacture of tocopheryl acetate (2007-01-30),

4. 6984744 - Phosphine ligands (2006-01-10),

5. 6348612 - Chiral amido-phosphine-phosphinite compounds (2002-02-19),

6. 6288280 - Racemization of atropisomeric bis(phosphine oxide) compounds (2001-09-11),

7. 6274735 - Process and intermediates for preparation of substituted piperidines (2001-08-14),

8. 6268499 - Process and intermediates for preparation of substituted piperidine-epoxides (2001-07-31),

9. 6162929 - Process for the manufacture of bisphosphine oxide and bisphosphonate (2000-12-19),

10. 5910606 - Process for making .alpha.,.beta.-unsaturated carboxylic acids (1999-06-08),

11. 5710322 - Optically active iminocarboxylic acid derivatives (1998-01-20),

12. 5543559 - Process for the enantioselective hydrogenation of ketosiophorone (1996-08-06),

13. 5536858 - Tetrasulfonated diphosphine compounds and metal complexes thereof for (1996-07-16),

14. 5488172 - Chiral phosphorus compounds (1996-01-30),

15. 5457219 - Phosphorus compounds (1995-10-10),

Title: Rudolf Schmid: A Pioneer in Pharmaceutical Innovation

Introduction

Rudolf Schmid, based in Basel, Switzerland, is an accomplished inventor with an impressive portfolio of 26 patents. His work focuses primarily on the development of pharmaceutical compounds, showcasing his commitment to advancing medical science and treatment options.

Latest Patents

One of Rudolf Schmid's most recent patents is related to a process for the preparation of (S)-4-fluoromethyl-dihydro-furan-2-one. This compound is significant for its application in preparing the DPP-IV inhibitor (S)-1, which is useful for the treatment and prophylaxis of diseases associated with DPP-IV. Additionally, he has developed a synthesis process for α-amino-β-alkoxy-carboxylic acid esters, which includes compounds that hold potential therapeutic benefits.

Career Highlights

Throughout his career, Rudolf Schmid has been associated with prominent companies such as Hoffmann-La Roche Inc. and Roche Vitamins Inc. His contributions to these organizations have been pivotal in the advancement of pharmaceutical research and development.

Collaborations

Rudolf Schmid has worked alongside esteemed colleagues, including Joseph Foricher and David L Coffen. These collaborations have enhanced the innovation and effectiveness of the projects he has undertaken, leading to significant scientific advancements.

Conclusion

Rudolf Schmid's dedication to pharmaceutical innovation is evident through his extensive patent portfolio and collaborative efforts. As he continues to push the boundaries of medical research, his contributions are sure to have a lasting impact on the industry and the treatment of various ailments.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

1 patent (CIPO):

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.